Perspectives on the Evolution of Stem Cell Therapy for Heart Failure.
作者信息
Tompkins Bryon, Balkan Wayne, Hare Joshua M
机构信息
Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, United States.
出版信息
EBioMedicine. 2015 Nov 26;2(12):1838-9. doi: 10.1016/j.ebiom.2015.11.043. eCollection 2015 Dec.
Abstract
摘要
相似文献
1
Perspectives on the Evolution of Stem Cell Therapy for Heart Failure.心力衰竭干细胞治疗的发展前景
EBioMedicine. 2015 Nov 26;2(12):1838-9. doi: 10.1016/j.ebiom.2015.11.043. eCollection 2015 Dec.
2
Stem cell therapy for heart disease-Meta-analysis may be misleading.用于治疗心脏病的干细胞疗法——荟萃分析可能会产生误导。
Int J Cardiol. 2016 Jan 15;203:351-2. doi: 10.1016/j.ijcard.2015.10.193. Epub 2015 Oct 26.
3
The (Pluri)Potential of Cell Therapy for Heart Failure.细胞治疗心力衰竭的（多）潜能
J Card Fail. 2023 Apr;29(4):514-516. doi: 10.1016/j.cardfail.2023.01.008.
4
Combined usage of stem cells in end-stage heart failure therapies.干细胞在终末期心力衰竭治疗中的联合应用。
J Cell Biochem. 2014 Jul;115(7):1217-24. doi: 10.1002/jcb.24782.
5
The Evolution of the Stem Cell Theory for Heart Failure.心力衰竭的干细胞理论的演变。
EBioMedicine. 2015 Nov 5;2(12):1871-9. doi: 10.1016/j.ebiom.2015.11.010. eCollection 2015 Dec.
6
Stem cell therapy for CHD: towards translation.用于冠心病的干细胞疗法：迈向临床应用
Cardiol Young. 2015 Aug;25 Suppl 2(0 2):58-66. doi: 10.1017/S1047951115000840.
7
[Perspectives in cardiac cell therapy].[心脏细胞治疗的前景]
Presse Med. 2007 Mar;36 Spec No 1:1S55-8.
8
Adult Stem Cell Therapy and Heart Failure, 2000 to 2016: A Systematic Review.成人干细胞治疗与心力衰竭：2000 年至 2016 年的系统评价。
JAMA Cardiol. 2016 Oct 1;1(7):831-841. doi: 10.1001/jamacardio.2016.2225.
9
[Stem cell therapy using autologous myoblast sheets for severe heart failure].[使用自体成肌细胞片进行干细胞治疗严重心力衰竭]
Nihon Rinsho. 2011 Sep;69 Suppl 7:537-42.
10
Stem cell therapy: a future treatment for heart failure?
Health News. 2005 May;11(5):2.
引用本文的文献
1
Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.比较间充质干细胞在缺血性与非缺血性扩张型心肌病中的疗效。
J Am Heart Assoc. 2018 Jul 12;7(14):e008460. doi: 10.1161/JAHA.117.008460.
本文引用的文献
1
The Evolution of the Stem Cell Theory for Heart Failure.心力衰竭的干细胞理论的演变。
EBioMedicine. 2015 Nov 5;2(12):1871-9. doi: 10.1016/j.ebiom.2015.11.010. eCollection 2015 Dec.
2
Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy.联合细胞疗法对慢性缺血性心肌病的协同作用。
J Am Coll Cardiol. 2015 Nov 3;66(18):1990-1999. doi: 10.1016/j.jacc.2015.08.879.
3
Comparative Efficacy of Intracoronary Allogeneic Mesenchymal Stem Cells and Cardiosphere-Derived Cells in Swine with Hibernating Myocardium.冠状动脉内同种异体间充质干细胞与心球衍生细胞对猪冬眠心肌的疗效比较
Circ Res. 2015 Sep 11;117(7):634-44. doi: 10.1161/CIRCRESAHA.115.306850. Epub 2015 Aug 13.
4
Cardiac Stem Cell Hybrids Enhance Myocardial Repair.心脏干细胞杂种增强心肌修复。
Circ Res. 2015 Sep 25;117(8):695-706. doi: 10.1161/CIRCRESAHA.115.306838. Epub 2015 Jul 30.
5
Mesenchymal Stem Cells as a Biological Drug for Heart Disease: Where Are We With Cardiac Cell-Based Therapy?间充质干细胞作为治疗心脏病的生物药物：基于细胞的心脏治疗进展如何？
Circ Res. 2015 Jul 17;117(3):229-33. doi: 10.1161/CIRCRESAHA.117.306306.
6
Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells.同种异体间充质干细胞通过刺激内皮祖细胞恢复心力衰竭中的内皮功能。
EBioMedicine. 2015 Mar 28;2(5):467-75. doi: 10.1016/j.ebiom.2015.03.020. eCollection 2015 May.
7
Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.经心内膜心肌间质干细胞和单核骨髓细胞治疗缺血性心肌病：TAC-HFT 随机试验。
JAMA. 2014 Jan 1;311(1):62-73. doi: 10.1001/jama.2013.282909.
8
Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction.联合应用人心肌干细胞和骨髓间充质干细胞增强疗效以减少心肌梗死后的梗死面积并恢复心功能。
Circulation. 2013 Jan 15;127(2):213-23. doi: 10.1161/CIRCULATIONAHA.112.131110. Epub 2012 Dec 5.
9
Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells.不同干细胞类型和亚群的直接比较显示，心球源性细胞具有更好的旁分泌效力和心肌修复效果。
J Am Coll Cardiol. 2012 Mar 6;59(10):942-53. doi: 10.1016/j.jacc.2011.11.029.
10
A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.一项随机、双盲、安慰剂对照、剂量递增的急性心肌梗死后静脉内输注成人异体间充质干细胞（Prochymal）的研究。
J Am Coll Cardiol. 2009 Dec 8;54(24):2277-86. doi: 10.1016/j.jacc.2009.06.055.
Zotero 插件